Real-world Evidence for Drugs, Biologics, and Devices - REdI 2020 Published 2020-08-31 Download video MP4 360p Download video MP4 720p Recommendations 49:07 Restructure of the Office of New Drugs (OND) - REdI 2020 03:56 FDA CDER Regulatory Science: Real World Evidence 3:46:10 An Introduction to the CDER Quantitative Medicine Center of Excellence 02:04 Opioid Use Disorder, New Biosimilar, Black Family Cancer Awareness Week, & more | In Your Day Ep. 6 01:48 The Future of Clinical Trials, The Real Cost Campaign, and Sun Safety Tips | FDA In Your Day Ep. 5 23:33 LACF and Acidified Foods Regulations and Requirements 2:26:13 Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval 7:00:43 185th Meeting of Vaccines and Related Biological Products Advisory Committee 00:26 Waterproof Sunscreen? Sun Safety Tips from Episode 5 of FDA In Your Day | Full Video on Channel 05:28 Episode 5 - On The Road with Jim Jones - April 2024 7:33:16 May 24, 2024 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 00:17 Can Cardiac "Organ on a Chip" Technology Help Drug Toxicology Researchers? (Full Video on Channel) 6:04:12 REdI Annual Conference 2024: CBER (Biologics) Innovation in Medical Product Development (Day 1 of 2) 7:26:41 June 10, 2024 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) 9:44:21 June 4, 2024 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) 49:45 Framework for FDA’s Real-World Evidence Program – Mar 15, 2019 1:12:24 Strategies to Increase Clinical Trial Participation for Diverse Communities: OMHHE REACH Consortium 01:33 Can Cardiac "Organ on a Chip" Technology Help Drug Toxicology Researchers? | Researching FDA 1:31:19 4th Annual National Black Family Cancer Awareness, Engaging the Generations, #BlackFamCan 7:42:03 REdI Annual Conference 2024: CBER (Biologics) Innovation in Medical Product Development (Day 2 of 2) Similar videos 18:13 Introduction To Real-World Evidence 27:06 MDUFA IV: Accessing and Using Real-World and Postmarket Data for Regulatory Decision-Making 02:31 What is Real-World Evidence? 12:01 Real-world evidence generation with David Thompson 03:48 Real world evidence: what is it and what can it tell us? 01:10 Generate Real World Evidence with Clinerion Real World Data 46:23 Optimising Real-World Evidence And Real-World Data 02:01 Using Real-World Data for FDA Regulatory Decision-Making 4:41:50 The State of Real-World Evidence Policy 48:18 Perspectives on Real-World Evidence: Assessing Its Use, Impact, and Role in the US and EU 02:17 Real World Evidence 1:32:09 An International Framework for Real-World Evidence Day 1: RWE Pilot Project Results 8:58:15 FDA Regulatory Education for Industry (REdI) – Devices and Biologics Track 59:29 Case Examples of Patient Centered Real World Evidence 02:42 Real-World Evidence: How Does It Differ From Randomized Controlled Trials? 58:15 The Role of Real World Evidence in Regulatory Decision Making 01:41 Drugs Biologics and Medical Devices regulatory affairs training course More results